Literature DB >> 19178404

Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins.

T D Fernández1, M J Torres, N Blanca-López, J L Rodríguez-Bada, E Gomez, G Canto, C Mayorga, M Blanca.   

Abstract

BACKGROUND: Skin test sensitivity in patients with immediate allergy to penicillins tends to decrease over time, but no information is available concerning in vitro tests. We analysed the negativization rates of two in vitro methods that determine specific immunoglobulin E (IgE) antibodies, the basophil activation test using flow cytometry (BAT) and the radioallergosorbent test (RAST), in immediate allergic reactions to penicillins.
METHODS: Forty-one patients with immediate allergic reactions to amoxicillin were followed up over a 4-year period. BAT and RAST were performed at 6-month intervals. Patients were randomized into groups: Group I, skin tests carried out at regular intervals; Group II, skin tests made only at the beginning of the study.
RESULTS: Differences were observed between RAST and BAT (P < 0.01), the latter showing earlier negativization. Considering different haptens, significant differences for the rate of negativization were only found for amoxicillin (P < 0.05). Comparisons between Groups I (n = 10) and II (n = 31) showed a tendency to become negative later in Group I with RAST.
CONCLUSIONS: Levels of specific IgE antibodies tended to decrease over time in patients with immediate allergic reactions to amoxicillin. Conversion to negative took longer for the RAST assay, although the differences were only detected with the amoxicillin hapten. Skin testing influenced the rate of negativization of the RAST assay, contributing to maintenance of in vitro sensitivity. Because of the loss of sensitivity over time, the determination of specific IgE antibodies to penicillins in patients with immediate allergic reactions must be done as soon as possible after the reaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19178404     DOI: 10.1111/j.1398-9995.2008.01713.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  26 in total

1.  [Cellular in-vitro assays. Applicability in daily routine].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

2.  Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance.

Authors:  Janni Hjortlund; Charlotte Gotthard Mortz; Tore Bjerregaard Stage; Per Stahl Skov; Ronald Dahl; Carsten Bindslev-Jensen
Journal:  Clin Transl Allergy       Date:  2014-10-29       Impact factor: 5.871

Review 3.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 4.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 5.  Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 6.  Response to Ebo et al., Letter to the Editor Regarding Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-04       Impact factor: 4.806

7.  Update on the management of antibiotic allergy.

Authors:  Bernard Yu-Hor Thong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

8.  Challenge Test Results in Patients With Suspected Penicillin Allergy, but No Specific IgE.

Authors:  Anne Holm; Holger Mosbech
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

Review 9.  Perioperative Anaphylaxis: Evaluation and Management.

Authors:  Deepti Vellaichamy Manian; Gerald W Volcheck
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-10       Impact factor: 8.667

10.  Immunologic evaluation of drug allergy.

Authors:  Enrique Gómez; Maria Jose Torres; Cristobalina Mayorga; Miguel Blanca
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-30       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.